Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CMPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MARCH9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WFDC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SEPT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR452 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNTG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT222 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALPK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLGAP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIRAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLCB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALS2CR11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADSSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on